Pink Sheet is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

Oncology Drug Costs Can Be ‘Financial Toxicity,’ ASCO Told

This article was originally published in The Pink Sheet Daily

Executive Summary

Memorial Sloan Kettering’s Saltz challenges oncology drug prices and urges a broader focus on value in a high-profile address to the ASCO annual meeting.

Advertisement

Related Content

Opdivo/Yervoy Data Show Role For Checkpoint Combos; ASCO Debates Biomarkers

Topics

Related Companies

Advertisement
UsernamePublicRestriction

Register